🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, single-sequence, drug-drug interaction study in heal...
Status
Completed
Location
Healthcare Discoveries, LLC d/b/a ICON Development Solutions
Start Date
2014-09
Trial ID
NCT02227173
Treatments Being Tested
This is an open-label, cross-over, fixed-sequence study. All subjects will ...
Status
Completed
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02473627
Treatments Being Tested
This study is an open-label drug-drug interaction (DDI) study of ZYN002 tra...
Status
Completed
Location
CMAX Clinical Research
Start Date
2025-06-06
Trial ID
NCT06930872
To study the Pharmacokinetics (PK) parameters of montelukast, flurbiprofen,...
Status
Completed
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02456844
The study is being conducted to assess the effect of BMS-986142 on the sing...
Status
Completed
Location
Ppd Development, Lp
Start Date
2016-05
Trial ID
NCT02762123
Human safety studies will be carried out to test whether red clover botanic...
Status
Completed
Location
University of Illinois at Chicago
Start Date
2019-04-01
Trial ID
NCT03948243
Treatments Being Tested
This study will evaluate the effects of nirogacestat 100 mg twice daily (BI...
Status
Completed
Location
ICON Martini Groningen CRU
Start Date
2025-10-27
Trial ID
NCT07259330
Treatments Being Tested
This is a Phase 1, open-label, 3-period study to determine radiprodil's pot...
Status
Completed
Location
Nucleus Network Melbourne
Start Date
2025-05-20
Trial ID
NCT06975605
Treatments Being Tested
The main purpose of this study is to determine the potential inhibitory/ind...
Status
Completed
Location
Clinical Pharmacology Unit
Start Date
2017-03-14
Trial ID
NCT03058419
The primary objective of this study will be to evaluate the drug-drug inter...
Status
Completed
Location
Celerion
Start Date
2016-01-14
Trial ID
NCT06004947
Treatments Being Tested